Sohn Elliott H, van Dijk Hille W, Jiao Chunhua, Kok Pauline H B, Jeong Woojin, Demirkaya Nazli, Garmager Allison, Wit Ferdinand, Kucukevcilioglu Murat, van Velthoven Mirjam E J, DeVries J Hans, Mullins Robert F, Kuehn Markus H, Schlingemann Reinier Otto, Sonka Milan, Verbraak Frank D, Abràmoff Michael David
Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology, University of Iowa, Iowa City, IA 52242;
Department of Ophthalmology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands;
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2655-64. doi: 10.1073/pnas.1522014113. Epub 2016 Apr 25.
Diabetic retinopathy (DR) has long been recognized as a microvasculopathy, but retinal diabetic neuropathy (RDN), characterized by inner retinal neurodegeneration, also occurs in people with diabetes mellitus (DM). We report that in 45 people with DM and no to minimal DR there was significant, progressive loss of the nerve fiber layer (NFL) (0.25 μm/y) and the ganglion cell (GC)/inner plexiform layer (0.29 μm/y) on optical coherence tomography analysis (OCT) over a 4-y period, independent of glycated hemoglobin, age, and sex. The NFL was significantly thinner (17.3 μm) in the eyes of six donors with DM than in the eyes of six similarly aged control donors (30.4 μm), although retinal capillary density did not differ in the two groups. We confirmed significant, progressive inner retinal thinning in streptozotocin-induced "type 1" and B6.BKS(D)-Lepr(db)/J "type 2" diabetic mouse models on OCT; immunohistochemistry in type 1 mice showed GC loss but no difference in pericyte density or acellular capillaries. The results suggest that RDN may precede the established clinical and morphometric vascular changes caused by DM and represent a paradigm shift in our understanding of ocular diabetic complications.
糖尿病视网膜病变(DR)长期以来一直被认为是一种微血管病变,但以视网膜内层神经变性为特征的视网膜糖尿病神经病变(RDN)也见于糖尿病(DM)患者。我们报告,在45例无DR或仅有轻微DR的DM患者中,在4年期间,光学相干断层扫描分析(OCT)显示神经纤维层(NFL)(每年0.25μm)和神经节细胞(GC)/内网状层(每年0.29μm)出现显著的进行性丢失,且与糖化血红蛋白、年龄和性别无关。6例DM供体眼中的NFL明显比6例年龄相仿的对照供体眼中的NFL薄(17.3μm对30.4μm),尽管两组的视网膜毛细血管密度无差异。我们在链脲佐菌素诱导的“1型”和B6.BKS(D)-Lepr(db)/J“2型”糖尿病小鼠模型中通过OCT证实了视网膜内层有显著的进行性变薄;1型小鼠的免疫组织化学显示GC丢失,但周细胞密度或无细胞毛细血管无差异。结果表明,RDN可能先于DM引起的既定临床和形态学血管变化出现,这代表了我们对糖尿病眼部并发症认识的范式转变。